University of Kiel
Dieter Kabelitz was a post-doc in Uppsala/Sweden and at Rockefeller University, New York. Back in Germany, he worked at the universities of Ulm and Heidelberg and the Federal Paul-Ehrlich Institute in Langen. From 1999 to 2018 he was a full professor at the University of Kiel and Director of the Institute of Immunology. Currently, he is the director emeritus and group leader at the Institute of Immunology. His scientific expertise is in the field of the functional characterization of human gamma/delta T cells. His major interest is to explore strategies how to increase the effector functions of these cells for the potential use in immunotherapy of cancer. He was the chairman of the Collaborative Research Center (SFB) 415 „Specificity and Pathophysiology of Signal Transduction Pathways“ at Kiel University funded by the German Research Foundation (DFG). He is a founding member of the DFG-funded Cluster of Excellence „Inflammation-at-Interfaces“. He was President of the German Society for Immunology (DGfI) in 2011 and 2012, and he is a Council member of the International Union of Immunological Societies (IUIS) and the current chair of the Education Committee (EDU) of IUIS.